353 related articles for article (PubMed ID: 33676596)
1. Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trial.
Van Dijck C; Tsoumanis A; Rotsaert A; Vuylsteke B; Van den Bossche D; Paeleman E; De Baetselier I; Brosius I; Laumen J; Buyze J; Wouters K; Lynen L; Van Esbroeck M; Herssens N; Abdellati S; Declercq S; Reyniers T; Van Herrewege Y; Florence E; Kenyon C
Lancet Infect Dis; 2021 May; 21(5):657-667. PubMed ID: 33676596
[TBL] [Abstract][Full Text] [Related]
2. The effect of daily usage of Listerine Cool Mint mouthwash on the oropharyngeal microbiome: a substudy of the PReGo trial.
Laumen JGE; Van Dijck C; Manoharan-Basil SS; de Block T; Abdellati S; Xavier BB; Malhotra-Kumar S; Kenyon C
J Med Microbiol; 2024 Jun; 73(6):. PubMed ID: 38833520
[No Abstract] [Full Text] [Related]
3. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
[TBL] [Abstract][Full Text] [Related]
4. Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.
Traeger MW; Cornelisse VJ; Asselin J; Price B; Roth NJ; Willcox J; Tee BK; Fairley CK; Chang CC; Armishaw J; Vujovic O; Penn M; Cundill P; Forgan-Smith G; Gall J; Pickett C; Lal L; Mak A; Spelman TD; Nguyen L; Murphy DA; Ryan KE; El-Hayek C; West M; Ruth S; Batrouney C; Lockwood JT; Hoy JF; Hellard ME; Stoové MA; Wright EJ;
JAMA; 2019 Apr; 321(14):1380-1390. PubMed ID: 30964528
[TBL] [Abstract][Full Text] [Related]
5. Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort.
van den Elshout MAM; Wijstma ES; Boyd A; Jongen VW; Coyer L; Anderson PL; Davidovich U; de Vries HJC; Prins M; Schim van der Loeff MF; Hoornenborg E;
PLoS Med; 2024 May; 21(5):e1004328. PubMed ID: 38718068
[TBL] [Abstract][Full Text] [Related]
6. Antiseptic mouthwash for gonorrhoea prevention (OMEGA): a randomised, double-blind, parallel-group, multicentre trial.
Chow EPF; Williamson DA; Hocking JS; Law MG; Maddaford K; Bradshaw CS; McNulty A; Templeton DJ; Moore R; Murray GL; Danielewski JA; Wigan R; Chen MY; Guy RJ; Zhang L; Donovan B; Grulich AE; Kaldor JM; Whiley DM; Cornelisse VJ; Howden BP; Lewis DA; Read TRH; Fairley CK
Lancet Infect Dis; 2021 May; 21(5):647-656. PubMed ID: 33676595
[TBL] [Abstract][Full Text] [Related]
7. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Doré V; Meyer L;
Lancet HIV; 2017 Sep; 4(9):e402-e410. PubMed ID: 28747274
[TBL] [Abstract][Full Text] [Related]
8. Real-world trends in incidence of bacterial sexually transmissible infections among gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) in Australia following nationwide PrEP implementation: an analysis of sentinel surveillance data.
Traeger MW; Guy R; Asselin J; Patel P; Carter A; Wright EJ; Grulich A; McManus H; Fairley CK; Chow EPF; McNulty A; Finlayson R; Bell C; Owen L; Marshall L; Russell D; O'Donnell D; Donovan B; Hellard ME; Stoové MA;
Lancet Infect Dis; 2022 Aug; 22(8):1231-1241. PubMed ID: 35643090
[TBL] [Abstract][Full Text] [Related]
9. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial.
Molina JM; Charreau I; Chidiac C; Pialoux G; Cua E; Delaugerre C; Capitant C; Rojas-Castro D; Fonsart J; Bercot B; Bébéar C; Cotte L; Robineau O; Raffi F; Charbonneau P; Aslan A; Chas J; Niedbalski L; Spire B; Sagaon-Teyssier L; Carette D; Mestre SL; Doré V; Meyer L;
Lancet Infect Dis; 2018 Mar; 18(3):308-317. PubMed ID: 29229440
[TBL] [Abstract][Full Text] [Related]
10. Daily and event-driven pre-exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence.
Vuylsteke B; Reyniers T; De Baetselier I; Nöstlinger C; Crucitti T; Buyze J; Kenyon C; Wouters K; Laga M
J Int AIDS Soc; 2019 Oct; 22(10):e25407. PubMed ID: 31663257
[TBL] [Abstract][Full Text] [Related]
11. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.
McCormack S; Dunn DT; Desai M; Dolling DI; Gafos M; Gilson R; Sullivan AK; Clarke A; Reeves I; Schembri G; Mackie N; Bowman C; Lacey CJ; Apea V; Brady M; Fox J; Taylor S; Antonucci S; Khoo SH; Rooney J; Nardone A; Fisher M; McOwan A; Phillips AN; Johnson AM; Gazzard B; Gill ON
Lancet; 2016 Jan; 387(10013):53-60. PubMed ID: 26364263
[TBL] [Abstract][Full Text] [Related]
12. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial.
Antoni G; Tremblay C; Delaugerre C; Charreau I; Cua E; Rojas Castro D; Raffi F; Chas J; Huleux T; Spire B; Capitant C; Cotte L; Meyer L; Molina JM;
Lancet HIV; 2020 Feb; 7(2):e113-e120. PubMed ID: 31784343
[TBL] [Abstract][Full Text] [Related]
13. Incidence of sexually transmitted infections and association with behavioural factors: Time-to-event analysis of a large pre-exposure prophylaxis (PrEP) cohort.
Hovaguimian F; Kouyos RD; Kusejko K; Schmidt AJ; Tarr PE; Bernasconi E; Braun DL; Calmy A; Notter J; Stoeckle M; Surial B; Christinet V; Darling KEA; Depmeier C; Läuchli S; Reinacher M; Rasi M; Nicca D; Bruggmann P; Haerry D; Bize R; Low N; Vock F; El Amari EB; Böni J; Bosshard PP; Fehr JS; Hampel B;
HIV Med; 2024 Jan; 25(1):117-128. PubMed ID: 37771207
[TBL] [Abstract][Full Text] [Related]
14. HIV pre-exposure prophylaxis and its implementation in the PrEP Impact Trial in England: a pragmatic health technology assessment.
Sullivan AK; Saunders J; Desai M; Cartier A; Mitchell HD; Jaffer S; Ogaz D; Chiavenna C; Charlett A; Diamente V; Golombek R; Manavi K; Priestley C; Waters LJ; Milinkovic A; McOwan A; Estcourt C; Sabin CA; Rodger A; Gold D; Gazzard BG; McCormack S; Gill ON;
Lancet HIV; 2023 Dec; 10(12):e790-e806. PubMed ID: 38040478
[TBL] [Abstract][Full Text] [Related]
15. A multicentre double-blind randomised controlled trial evaluating the efficacy of daily use of antibacterial mouthwash against oropharyngeal gonorrhoea among men who have sex with men: the OMEGA (Oral Mouthwash use to Eradicate GonorrhoeA) study protocol.
Chow EPF; Walker S; Hocking JS; Bradshaw CS; Chen MY; Tabrizi SN; Howden BP; Law MG; Maddaford K; Read TRH; Lewis DA; Whiley DM; Zhang L; Grulich AE; Kaldor JM; Cornelisse VJ; Phillips S; Donovan B; McNulty AM; Templeton DJ; Roth N; Moore R; Fairley CK
BMC Infect Dis; 2017 Jun; 17(1):456. PubMed ID: 28659133
[TBL] [Abstract][Full Text] [Related]
16. Sexually transmitted infections incidence in young Thai men who have sex with men and transgender women using HIV pre-exposure prophylaxis.
Songtaweesin WN; Pornpaisalsakul K; Kawichai S; Wacharachaisurapol N; Wongharn P; Yodkitudomying C; Panichnantakul P; Theerawit T; Pankam T; Puthanakit T
Int J STD AIDS; 2022 Apr; 33(5):447-455. PubMed ID: 35282719
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of Kenyan women using HIV PrEP enrolled in a randomized trial on doxycycline postexposure prophylaxis for sexually transmitted infection prevention.
Oware K; Adiema L; Rono B; Violette LR; McClelland RS; Donnell D; Scoville CW; Odoyo J; Baeten JM; Bukusi E; Stewart J
BMC Womens Health; 2023 Jun; 23(1):296. PubMed ID: 37270546
[TBL] [Abstract][Full Text] [Related]
18. Incidence and Correlates of Sexually Transmitted Infections Among Black Men Who Have Sex With Men Participating in the HIV Prevention Trials Network 073 Preexposure Prophylaxis Study.
Hightow-Weidman LB; Magnus M; Beauchamp G; Hurt CB; Shoptaw S; Emel L; Piwowar-Manning E; Mayer KH; Nelson LE; Wilton L; Watkins P; Whitfield D; Fields SD; Wheeler D
Clin Infect Dis; 2019 Oct; 69(9):1597-1604. PubMed ID: 30615169
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Trends in Rates of Sexually Transmitted Infections Before vs After Initiation of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men.
McManus H; Grulich AE; Amin J; Selvey C; Vickers T; Bavinton B; Zablotska I; Vaccher S; Jin F; Holden J; Price K; Yeung B; Cabrera Quichua G; Ogilvie E; McNulty A; Smith D; Guy R
JAMA Netw Open; 2020 Dec; 3(12):e2030806. PubMed ID: 33355675
[TBL] [Abstract][Full Text] [Related]
20. The impact of COVID-19-related restrictions in 2020 on sexual healthcare use, pre-exposure prophylaxis use, and sexually transmitted infection incidence among men who have sex with men in Amsterdam, the Netherlands.
de la Court F; Boyd A; Coyer L; van den Elshout M; de Vries HJC; Matser A; Hoornenborg E; Prins M;
HIV Med; 2023 Feb; 24(2):212-223. PubMed ID: 36226479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
